{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:37:01Z","timestamp":1789504621447,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008781","name":"Pomeranian Medical University in Szczecin","doi-asserted-by":"crossref","award":["WNoZ-322-01\/S\/19\/2023"],"award-info":[{"award-number":["WNoZ-322-01\/S\/19\/2023"]}],"id":[{"id":"10.13039\/501100008781","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The effect of multidrug immunosuppressive protocols on the salivary glands is still unknown. This study aimed to determine the influence of immunosuppressive regimens based on calcineurin inhibitors (CNIs) and conversion to rapamycin on the morphology, apoptosis, and proliferation of rat salivary glands.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Male rats received cyclosporin A (CsA), tacrolimus (FK-506), mycophenolate mofetil (MMF), rapamycin (Rapa), and prednisone (Pre) according to three-drug protocols: CMP (CsA, MMF, and Pre), CMP\/R (CsA, MMF, and Pre with conversion to Rapa), TMP (FK-506, MMF, and Pre), and TMP\/R (FK-506, MMF, and Pre with conversion to Rapa). Morphological and immunohistochemical and quantitative analyses of the salivary glands were performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Structural changes in salivary glands were observed in all experimental groups, especially in the submandibular gland. In the salivary glands, the percentages of collagen fibers and TUNEL-, Ki67- and PCNA-positive cells were higher in the experimental groups vs. the control but were lower in the CMP\/R and TMP\/R groups vs. the CMP and TMP groups, with the exception of collagen fibers in the parotid gland in the TMP\/R group vs. the TMP group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Long-term administration of CNIs in triple regimens and after conversion to rapamycin monotherapy, causes morphological changes in the salivary glands of rats. Immunosuppressive treatment based on CNIs is associated with an increase in collagen accumulation. The effects of the conversion of treatment with CNIs to rapamycin in immunosuppressive protocols in rat salivary glands lead to decreased fibrosis, apoptosis, and proliferation. These changes may possibly prevent abnormalities resulting from the application of CNIs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s43440-023-00521-0","type":"journal-article","created":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T11:01:40Z","timestamp":1693652500000},"page":"1240-1253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The long-term effects of multidrug immunosuppressive protocols based on calcineurin inhibitors and conversion to rapamycin on the morphology, apoptosis, and proliferation of rat salivary glands"],"prefix":"10.1007","volume":"75","author":[{"given":"Marta","family":"Grabowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"K\u0119dzierska-Kapuza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Kram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leszek","family":"Teresi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olimpia","family":"Sipak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Piasecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,2]]},"reference":[{"key":"521_CR1","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.3390\/jcm11051392","volume":"11","author":"H Oweira","year":"2022","unstructured":"Oweira H, Ramouz A, Ghamarnejad O, Khajeh E, Ali-Hasan-Al-Saegh S, Nikbakhsh R, et al. Risk factors of rejection in renal transplant recipients: a narrative review. J Clin Med. 2022;11:1392. https:\/\/doi.org\/10.3390\/jcm11051392.","journal-title":"J Clin Med"},{"key":"521_CR2","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.2147\/TCRM.S164323","volume":"14","author":"YF Tsai","year":"2018","unstructured":"Tsai YF, Liu FC, Kuo CF, Chung TT, Yu HP. Graft outcomes following immunosuppressive therapy with different combinations in kidney transplant recipients: a nationwide cohort study. Ther Clin Risk Manage. 2018;14:1099\u2013110. https:\/\/doi.org\/10.2147\/TCRM.S164323.","journal-title":"Ther Clin Risk Manage"},{"key":"521_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.29245\/2578-3009\/2019\/4.1178","volume":"3","author":"E Claeys","year":"2019","unstructured":"Claeys E, Vermeire K. Immunosuppressive drugs in organ transplantation to prevent allograft rejection: mode of action and side effects. J Immunol Sci. 2019;3:14\u201321. https:\/\/doi.org\/10.29245\/2578-3009\/2019\/4.1178.","journal-title":"J Immunol Sci"},{"key":"521_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.ackd.2019.08.006","volume":"27","author":"SS Farouk","year":"2020","unstructured":"Farouk SS, Rein JL. The many faces of calcineurin inhibitor toxicity\u2014what the FK? Adv Chronic Kidney Dis. 2020;27:56\u201366. https:\/\/doi.org\/10.1053\/j.ackd.2019.08.006.","journal-title":"Adv Chronic Kidney Dis"},{"key":"521_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","volume":"19","author":"J Li","year":"2014","unstructured":"Li J, Kim SG, Blenis J. Rapamycin: one drug, many effects. Cell Metab. 2014;19:373\u20139. https:\/\/doi.org\/10.1016\/j.cmet.2014.01.001.","journal-title":"Cell Metab"},{"key":"521_CR6","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1016\/j.transproceed.2021.09.019","volume":"53","author":"AR de Souza","year":"2021","unstructured":"de Souza AR, Dos Santos TAGM, Von Jakitsch CB, de Sant\u2019Anna ALGG, de Claudio JCM, Branco JNR, et al. Mammalian target of rapamycin inhibitors vs calcineurin inhibitors in chronic graft rejection after lung transplantation: a systematic review and meta-analysis. Transplant Proc. 2021;53:3056\u201364. https:\/\/doi.org\/10.1016\/j.transproceed.2021.09.019.","journal-title":"Transplant Proc"},{"key":"521_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.18632\/oncotarget.28410","volume":"14","author":"MV Blagosklonny","year":"2023","unstructured":"Blagosklonny MV. Cancer prevention with rapamycin. Oncotarget. 2023;14:342\u201350. https:\/\/doi.org\/10.18632\/oncotarget.28410.","journal-title":"Oncotarget"},{"key":"521_CR8","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.3390\/curroncol30060421","volume":"30","author":"L Todeschini","year":"2023","unstructured":"Todeschini L, Cristin L, Martinino A, Mattia A, Agnes S, Giovinazzo F. The role of mTOR inhibitors after liver transplantation for hepatocellular carcinoma. Curr Oncol. 2023;30:5574\u201392. https:\/\/doi.org\/10.3390\/curroncol30060421.","journal-title":"Curr Oncol"},{"key":"521_CR9","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/phar.2799","volume":"43","author":"C Ye","year":"2023","unstructured":"Ye C, Li J, Liu X, Yan J, Chen J, Wang C, et al. The incidence of cytomegalovirus and BK polyomavirus infections in kidney transplant patients receiving mTOR inhibitors: a systematic review and meta-analysis. Pharmacotherapy. 2023;43:552\u201362. https:\/\/doi.org\/10.1002\/phar.2799.","journal-title":"Pharmacotherapy"},{"key":"521_CR10","doi-asserted-by":"publisher","first-page":"8609547","DOI":"10.1155\/2019\/8609547","volume":"2019","author":"R Malek","year":"2019","unstructured":"Malek R, El Houari B, Kissa J. Periodontal management of cyclosporin a-induced gingival overgrowth: a nonsurgical approach. Case Rep Dent. 2019;2019:8609547. https:\/\/doi.org\/10.1155\/2019\/8609547.","journal-title":"Case Rep Dent"},{"key":"521_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/antibiotics8030124","volume":"8","author":"B Rapone","year":"2019","unstructured":"Rapone B, Ferrara E, Santacroce L, Cesarano F, Arazzi M, Liberato LD, et al. Periodontal microbiological status influences the occurrence of cyclosporine-A and tacrolimus-induced gingival overgrowth. Antibiotics (Basel). 2019;8:124. https:\/\/doi.org\/10.3390\/antibiotics8030124.","journal-title":"Antibiotics (Basel)"},{"key":"521_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/00016357.2019.1685680","volume":"78","author":"DJS Sarmento","year":"2020","unstructured":"Sarmento DJS, Aires Antunes RSCC, Cristelli M, Braz-Silva PH, Maciel R, Pestana JOMA, et al. Oral manifestations of allograft recipients immediately before and after kidney transplantation. Acta Odontol Scand. 2020;78:217\u201322. https:\/\/doi.org\/10.1080\/00016357.2019.1685680.","journal-title":"Acta Odontol Scand"},{"key":"521_CR13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.20471\/acc.2016.55.03.15","volume":"55","author":"K Levarda-Hudolin","year":"2016","unstructured":"Levarda-Hudolin K, Hudolin T, Ba\u0161i\u0107-Juki\u0107 N, Ka\u0161telan \u017d. Oral lesions in kidney transplant recipients. Acta Clin Croat. 2016;55:459\u201363. https:\/\/doi.org\/10.20471\/acc.2016.55.03.15.","journal-title":"Acta Clin Croat"},{"key":"521_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000049022","volume":"9","author":"JM Giglio","year":"2001","unstructured":"Giglio JM, Vatta MS, Bianciotti LG, Lomniczi A, Elverdin JC. Cyclosporin A: effects on the secretory process and noradrenergic activity in the submandibular gland of the rat. Neuroimmunomodulation. 2001;9:170\u20136. https:\/\/doi.org\/10.1159\/000049022.","journal-title":"Neuroimmunomodulation"},{"key":"521_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1601-0825.2009.01609.x","volume":"16","author":"RM L\u00f3pez-Pintor","year":"2010","unstructured":"L\u00f3pez-Pintor RM, Hern\u00e1ndez G, de Arriba L, de Andr\u00e9s A. Comparison of oral lesion prevalence in renal transplant patients under immunosuppressive therapy and healthy controls. Oral Dis. 2010;16:89\u201395. https:\/\/doi.org\/10.1111\/j.1601-0825.2009.01609.x.","journal-title":"Oral Dis"},{"key":"521_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/s0300-483x(95)03278-n","volume":"108","author":"AR Dehpour","year":"1996","unstructured":"Dehpour AR, Nouhnejad P, Mousavizadeh K, Ghafourifar P, Djamali M, Borhanimoghadam B. Cyclosporin A-induced functional and morphological changes in pilocarpine treated rat submandibular glands. Toxicology. 1996;108:65\u201371. https:\/\/doi.org\/10.1016\/s0300-483x(95)03278-n.","journal-title":"Toxicology"},{"key":"521_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2015.04.022","volume":"134","author":"LC Spolidorio","year":"2015","unstructured":"Spolidorio LC, Herrera BS, Coimbra LS, de Andrade CR, Spolidorio DM, Rossa Junior C, et al. The long-term administration of calcineurin inhibitors decreases antioxidant enzyme activity in the rat parotid and submandibular salivary glands. Life Sci. 2015;134:1\u20138. https:\/\/doi.org\/10.1016\/j.lfs.2015.04.022.","journal-title":"Life Sci"},{"key":"521_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.21608\/scumj.2019.44181","volume":"22","author":"S Soliman","year":"2019","unstructured":"Soliman S, Ghali L, Taha R. The effect of the immunosuppressive drug sirolimus on structure of the submandibular salivary glands of the rat. Suez Canal Univ Med J. 2019;22:18\u201328. https:\/\/doi.org\/10.21608\/scumj.2019.44181.","journal-title":"Suez Canal Univ Med J"},{"key":"521_CR19","doi-asserted-by":"publisher","first-page":"4614","DOI":"10.3390\/ijerph17124614","volume":"17","author":"M Grabowska","year":"2020","unstructured":"Grabowska M, Laszczy\u0144ska M, K\u0119dzierska-Kapuza K, Kram A, Gill K, Piasecka M. The effects of long-term immunosuppressive therapies on the structure of the rat prostate. Int J Environ Res Public Health. 2020;17:4614. https:\/\/doi.org\/10.3390\/ijerph17124614.","journal-title":"Int J Environ Res Public Health"},{"key":"521_CR20","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.14670\/HH-11-606","volume":"30","author":"M Grabowska","year":"2015","unstructured":"Grabowska M, S\u0142uczanowska-G\u0142\u0105bowska S, Kram A, Teresi\u0144ski L, Piasecka M, Podhorska-Oko\u0142\u00f3w M, et al. The influence of immunosuppressants on the morphology, proliferating cell nuclear antigen (PCNA) and apoptosis in the rat ventral prostate. Histol Histopathol. 2015;30:1089\u2013100. https:\/\/doi.org\/10.14670\/HH-11-606.","journal-title":"Histol Histopathol"},{"key":"521_CR21","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.nut.2005.04.002","volume":"21","author":"R Quinn","year":"2005","unstructured":"Quinn R. Comparing rat\u2019s to human\u2019s age: how old is my rat in people years? Nutrition. 2005;21:775\u20137. https:\/\/doi.org\/10.1016\/j.nut.2005.04.002.","journal-title":"Nutrition"},{"key":"521_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.108","volume":"5","author":"SS Bozorgi","year":"2014","unstructured":"Bozorgi SS, Proctor GB, Carpenter GH. Rapamycin delays salivary gland atrophy following ductal ligation. Cell Death Dis. 2014;5: e1146. https:\/\/doi.org\/10.1038\/cddis.2014.108.","journal-title":"Cell Death Dis."},{"key":"521_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"TA Wynn","year":"2008","unstructured":"Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214:199\u2013210. https:\/\/doi.org\/10.1002\/path.2277.","journal-title":"J Pathol"},{"key":"521_CR24","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1046\/j.1365-2168.2000.01576.x","volume":"87","author":"S Jain","year":"2000","unstructured":"Jain S, Bicknell GR, Nicholson ML. Tacrolimus has less fibrogenic potential than cyclosporin A in a model of renal ischaemia-reperfusion injury. Br J Surg. 2000;87:1563\u20138. https:\/\/doi.org\/10.1046\/j.1365-2168.2000.01576.x.","journal-title":"Br J Surg"},{"key":"521_CR25","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.2147\/DDDT.S111695","volume":"10","author":"M Grabowska","year":"2016","unstructured":"Grabowska M, K\u0119dzierska K, Micha\u0142ek K, S\u0142uczanowska-G\u0142\u0105bowska S, Grabowski M, Piasecka M, et al. Effects of an immunosuppressive treatment on the rat prostate. Drug Des Dev Ther. 2016;10:2899\u2013915. https:\/\/doi.org\/10.2147\/DDDT.S111695.","journal-title":"Drug Des Dev Ther"},{"key":"521_CR26","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1097\/01.tp.0000209412.77312.69","volume":"81","author":"B Yang","year":"2006","unstructured":"Yang B, Jain S, Ashra SY, Furness PN, Nicholson ML. Apoptosis and caspase-3 in long-term renal ischemia\/reperfusion injury in rats and divergent effects of immunosuppressants. Transplantation. 2006;81:1442\u201350. https:\/\/doi.org\/10.1097\/01.tp.0000209412.77312.69.","journal-title":"Transplantation"},{"key":"521_CR27","doi-asserted-by":"publisher","first-page":"20271","DOI":"10.18632\/oncotarget.7941","volume":"7","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, Pang B, Iglesias-Bartolome R, Wu X, Hu L, Zhang C, et al. Prevention of irradiation-induced salivary hypofunction by rapamycin in swine parotid glands. Oncotarget. 2016;7:20271\u201381. https:\/\/doi.org\/10.18632\/oncotarget.7941.","journal-title":"Oncotarget"},{"key":"521_CR28","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12935-022-02706-8","volume":"22","author":"ES Ali","year":"2022","unstructured":"Ali ES, Mitra K, Akter S, Ramproshad S, Mondal B, Khan IN, et al. Recent advances and limitations of mTOR inhibitors in the treatment of cancer. Cancer Cell Int. 2022;22:284. https:\/\/doi.org\/10.1186\/s12935-022-02706-8.","journal-title":"Cancer Cell Int"},{"issue":"9","key":"521_CR29","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s40262-017-0626-1","volume":"57","author":"M Ghareeb","year":"2018","unstructured":"Ghareeb M, Gohh RY, Akhlaghi F. Tacrolimus concentration in saliva of kidney transplant recipients: factors influencing the relationship with whole blood concentrations. Clin Pharmacokinet. 2018;57(9):1199\u2013210. https:\/\/doi.org\/10.1007\/s40262-017-0626-1.","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"521_CR30","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s40261-019-00844-y","volume":"39","author":"E Brooks","year":"2019","unstructured":"Brooks E, Tett SE, Isbel NM, McWhinney B, Staatz CE. Investigation of the association between total and free plasma and saliva mycophenolic acid concentrations following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipients. Clin Drug Investig. 2019;39(12):1175\u201384. https:\/\/doi.org\/10.1007\/s40261-019-00844-y.","journal-title":"Clin Drug Investig"},{"issue":"2","key":"521_CR31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s40368-020-00573-3","volume":"22","author":"E Davidovich","year":"2021","unstructured":"Davidovich E, Polak D, Brand HS, Shapira J, Shapiro R. Salivary biochemical variables in liver transplanted children and young adults. Eur Arch Paediatr Dent. 2021;22(2):257\u201363. https:\/\/doi.org\/10.1007\/s40368-020-00573-3.","journal-title":"Eur Arch Paediatr Dent"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-023-00521-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-023-00521-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-023-00521-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T03:51:37Z","timestamp":1695959497000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-023-00521-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,2]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["521"],"URL":"https:\/\/doi.org\/10.1007\/s43440-023-00521-0","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,2]]},"assertion":[{"value":"28 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}